Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer (Q35011129)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42532150)
(Q80164282)
(Q90949746)
(P304) 7099-7105
(P407) (Q1860)
(P433) 22
(P478) 15
(P577) Tuesday, November 3, 2009
(P921) (Q424760)
(Q26981430)
(Q181257)
(P1433) (Q332253)
(P1476) "Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer" (language: en)
(P2093) Meredith M Regan
Yoo-Joung Ko
Glenn J Bubley
Stephen E Duggan
Lillian Werner
Christopher W Ryan
Paul Mathew
Shi-Ming Tu
Samuel R Denmeade
William K Oh
Oliver Sartor
Christos S Mantzoros
Roger Rittmaster
Steven P Balk
(P2860) (Q36504117)
(Q39954334)
(Q34798892)
(Q37213413)
(Q36876865)
(Q37002111)
(Q40213081)
(Q35127580)
(Q33235187)
(Q36309725)
(Q39675435)
(Q35083279)
(Q30312036)
(Q34534815)
(Q33767866)
(Q28609380)
(Q41615181)
(Q34314274)
(Q41344070)
(Q53744148)
(Q46417821)
(Q46034695)
(Q46586610)
(Q45149773)
(Q44799712)
(Q43627769)
(Q70593557)
(Q73585204)
(Q73944620)
(Q77374114)
other details
description scientific article

External Links